J
John J. Murray
Researcher at Langley Research Center
Publications - 121
Citations - 7682
John J. Murray is an academic researcher from Langley Research Center. The author has contributed to research in topics: Asthma & Internal medicine. The author has an hindex of 33, co-authored 113 publications receiving 7038 citations. Previous affiliations of John J. Murray include UK Astronomy Technology Centre & Vanderbilt University Medical Center.
Papers
More filters
Journal ArticleDOI
Development of the asthma control test: A survey for assessing asthma control
Robert A. Nathan,Christine A. Sorkness,Mark Kosinski,Michael Schatz,James T.C. Li,Philip Marcus,John J. Murray,T.B. Pendergraft +7 more
TL;DR: Results reinforce the usefulness of a brief, easy to administer, patient-based index of asthma control.
Journal ArticleDOI
Asthma Control Test: Reliability, validity, and responsiveness in patients not previously followed by asthma specialists
Michael Schatz,Christine A. Sorkness,James T.C. Li,Philip Marcus,John J. Murray,Robert A. Nathan,Mark Kosinski,T.B. Pendergraft,Priti Jhingran +8 more
TL;DR: The reliability and validity of the Asthma Control Test is evaluated in a longitudinal study of asthmatic patients new to the care of an asthma specialist, finding a cutoff score of 19 or less identifies patients with poorly controlled asthma.
Journal ArticleDOI
Release of Prostaglandin D2 into Human Airways during Acute Antigen Challenge
John J. Murray,André-Bernard Tonnel,Alan R. Brash,L J Roberts nd,Philippe Gosset,R Workman,A Capron,John A. Oates +7 more
TL;DR: Evidence is provided that the release of prostaglandin D2 into the airways is an early event after the instillation of D. pteronyssinus in patients who are sensitive to this antigen.
Journal ArticleDOI
The Safety and Efficacy of Infliximab in Moderate to Severe Chronic Obstructive Pulmonary Disease
Stephen I. Rennard,Charles Fogarty,Steven G. Kelsen,William Long,Joe W. Ramsdell,James Allison,Donald A. Mahler,Constantine Saadeh,Thomas Siler,Phillip Snell,Phillip Korenblat,William L. Smith,Mitchell Kaye,Michael Mandel,Charles E. Andrews,Rachakonda Prabhu,James F. Donohue,Rosemary Watt,Kim Hung Lo,Rozsa Schlenker-Herceg,Elliot S. Barnathan,John J. Murray +21 more
TL;DR: Subjects with moderate to severe COPD did not benefit from treatment with infliximab and the impact of inflIXimab on malignancy risk in patients with COPD needs to be further elucidated.
Journal ArticleDOI
Biochemical evidence of a chronic abnormality in platelet and vascular function in healthy individuals who smoke cigarettes.
TL;DR: Evidence of platelet and vascular dysfunction in vivo in chronic cigarette smokers before the manifestation of overt cardiovascular disease is found, indicating that excessive thromboxane A2 generation in chronic smokers predominantly derives from platelets.